NCT07130838Not yet recruiting
EAT SMART Teen Study
Effects of Application-based Eating Awareness Training on Disordered Eating in Youth With Obesity: The EAT SMART Teen Study
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The goal of this controlled trial is to assess the feasability and efficacy of a 12-week mindfulness-based intervention (MBI) in adolescents living with obesity. The study will include youth ages 12 to 17 who are waitlisted at the Centre for Healthy Active Living (CHAL) at the Children's Hospital of Eastern Ontario (CHEO). We hypothesize that the MB-EAT Teen intervention will demonstrate good feasibility and usability among adolescents living with obesity. We also expect that, compared with the EAT SMART Teen psychoeducation program, MB-EAT Teen may lead to greater improvements in disordered eating behaviours, food-related self-regulation, mindfulness, emotional well-being, body image, and health-related quality of life.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- First submitted
- 11 Aug 2025
- Start date
- 1 Dec 2026
- Primary completion date
- 1 Apr 2028
- Lead sponsor
- Gary Goldfield
- Diseases
- Obesity
- NCT number
- NCT07130838
What you commit to
- Study type: Interventional
- Planned participants: 170
- From 1 Dec 2026 to the primary completion date, 1 Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have previously been diagnosed with Bulimia Nervosa, purging subtype
- Have previously been diagnosed with a condition that may impair their participation (e.g. cognition and/or neurodevelopment, particularly Fetal Alcohol Syndrome, Autism Spectrum Disorder (ASD), Down Syndrome, Prader- Willi Syndrome, Fragile X Syndrome)
- Have previously been diagnosed with a neurodevelopmental disorder (e.g., ADHD) and symptoms are not controlled by medication
Other
- Are currently enrolled in a weight management program
- Have been diagnosed with a concussion in the past 6-months
Who the study is looking for
- Have access to a mobile/tablet device with internet access
- Are aged 12-17 years
- Are waitlisted or have recently been waitlisted for treatment at CHAL at CHEO
- Must sign and date the informed consent form, or provide assent and have a Substitute Decision Maker (SDM) provide informed consent
- Have the ability to complete the study in English
Age in the registry: 12 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children'S Hospital Of Eastern Ontario Coordinator of this site? Confirm its status | Ottawa | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.